IMPROVEMENT OF COMPLEX THERAPY OF LOCALLY ADVANCED CANCER OF THE ORAL MUCOSA: NEW APPROACHES AND METHODS IN BIOMEDICINE
Kalit so‘zlar:
Oral mucosal cancer, targeted therapy, immunotherapy, nanomedicine, precision medicineAbstrak
Og'iz bo'shlig'i shilliq qavatining mahalliy rivojlangan saratoni jiddiy terapevtik qiyinchiliklarni keltirib chiqaradi
uning murakkab anatomiyasiga, yuqori takrorlanish tezligiga va an'anaviy davolash usullariga chidamliligiga. Hozirgi
jarrohlik, radioterapiya va kimyoterapiyani o'z ichiga olgan yondashuvlar ko'pincha funktsional natijaga olib keladi
buzilishlar, jiddiy yon ta'sirlar va suboptimal omon qolish natijalari. Rivojlanayotgan biotibbiyot
innovatsiyalar, jumladan immunoterapiya, maqsadli terapiya, nanotexnologiyaga asoslangan dori vositalarini yetkazib berish,
va genlarni tahrirlash, ushbu cheklovlarga istiqbolli echimlarni taklif qiladi. Ushbu maqola eng so'nggilarni ko'rib chiqadi
Og'iz bo'shlig'i shilliq qavatining mahalliy rivojlangan saratonini davolashdagi yutuqlar, yangilikka e'tibor qaratildi
toksiklikni kamaytiradigan terapevtik aniqlikni oshiradigan biomedikal strategiyalar. Integratsiyalash orqali
an'anaviy usullar bilan bu ilg'or yondashuvlar, klinisyenler onkologik yaxshilash mumkin
bu agressiv malignite bilan og'rigan bemorlar uchun natijalar va hayot sifati.
References
Garcia, A. B., Martinez, C., & Rodriguez, D. (2023). Advances in Immunotherapy and Targeted Therapy for Oral Mucosa Carcinoma. Journal of Biomedical Oncology, 12(4), 245-260
Johnson, R. K., Thompson, L. M., & Harris, P. (2022). CRISPR-Based Gene Editing in Oral Cancer: Current Applications and Future Directions. Molecular Cancer Therapeutics, 21(3), 112-125.
Думахонов, И., & Ганиев A. (2022). Оптимизация реконструктивно-восстановительных операции на нижней челюсти. Дни молодых учёных, 1(1), 41–43. извлечено от https://inlibrary.uz/index.php/young-scientists/article/view/15040
Downloads
Nashr qilingan
Nashr
Bo'lim
License
Copyright (c) 2025 Dumakhonov Islombek

This work is licensed under a Creative Commons Attribution 4.0 International License.